BioCatalyst

Utidelone, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine — catalyst calendar

1 verified catalyst event(s) referencing Utidelone, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-15
in 4mo
ESTIMATED
 READOUT
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HE
Phase 2 · HER2-negative Breast Cancer Patients With Brain Metastases
 Biostar Pharma, Inc. Utidelone, Utidelone in combination with ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.